AKT2 and breast carcinoma: Interestingly, although WDR26 selectively regulates PI3Kβ and AKT2 signaling, its activity on breast cancer cell growth and migration does not seem to depend on the status of PI3Kα mutation, PTEN expression or RTK overexpression.